Activist investor Jana Partners takes stake in Cooper Cos., WSJ says
Barry Rosenstein, the founder of JANA Partners, a well-known hedge fund, is making headlines once again. The fund, known for pressuring companies to make strategic changes that benefit shareholders, is now setting its sights on Cooper, a medical devices company. According to sources close to the matter cited by the Wall Street Journal, JANA Partners plans to push Cooper to enhance its capital allocation strategies to drive better returns for investors.
When contacted by CNBC for a comment on the matter, JANA Partners did not immediately respond. However, reports suggest that the hedge fund may suggest that Cooper explore the possibility of merging its contact lens business with its competitor, Bausch + Lomb. This move could potentially create synergies and strengthen Cooper’s position in the market.
Cooper has been facing challenges recently, with the company lowering its full-year revenue forecast in August due to weaker demand in certain markets. As a result, the stock has declined by nearly 22% this year. With JANA Partners’ involvement, shareholders are hopeful that the fund’s activism will lead to positive changes and drive the company towards a path of growth and profitability.
For more information on this story, you can read the original article from the Wall Street Journal by clicking here. Stay tuned for updates on how JANA Partners’ activism could impact Cooper and its future prospects.
